Rising caregiver depression, care hours evident up to 10 years before a partner’s dementia diagnosis
By
Alicia Lasek
Sep 08, 2022
An increase in caregiving hours and depressive symptoms are detectable in caregivers at least 10 years before their partner is diagnosed with cognitive impairment, a new study finds.
Clinical briefs for Thursday, Sept. 8
By
Alicia Lasek
Sep 08, 2022
Pfizer’s COVID pill Paxlovid has profound effect in seniors, NEJM study finds … SNFs can access free COVID testing for staff, residents through Dec. 31 … Researchers identify risk of COVID and its...
59.5 percent of adult ED visits are for patients with chronic conditions tied to COVID risk
Sep 02, 2022
Patients with chronic conditions tied to a high risk of severe COVID-19 account for nearly 60% of ED visits, investigators say.
Seniors with spine fracture may avoid surgery with 2 weeks of bed rest
By
Alicia Lasek
Sep 07, 2022
Older adults with osteoporotic spine fractures who have a poor prognosis are less likely to require surgery if they are initially prescribed strict bed rest, a new study finds.
Focus on hand coordination could improve stroke therapy outcomes: study
By
Alicia Lasek
Sep 07, 2022
Stroke may affect some bimanual tasks more than others, leaving room for significant improvements in capabilities, investigators say.
Insomnia increases odds of memory decline in older adults
By
Alicia Lasek
Sep 07, 2022
Insomnia may be an important target for early intervention to help prevent age-related cognitive decline, investigators say.
Clinical briefs for Wednesday, Sept. 7
By
Alicia Lasek
Sep 07, 2022
CVS makes $8B acquisition to advance house calls … Biden administration asks Congress for more than $26B in COVID funds for 2023 … Nurse administrator tapped to revamp CDC … Global plan launched...
FDA authorizes omicron-targeting vaccines as preferred COVID booster shots
By
Alicia Lasek
Sep 01, 2022
The FDA has authorized new, bivalent versions of Pfizer’s and Moderna’s COVID-19 vaccines to be used as booster shots. At the same time, the original monovalent versions are no longer authorized as...
Use of deauthorized COVID antibody treatments widespread in early 2022: study
By
Alicia Lasek
Sep 01, 2022
Some U.S. clinicians continued to rely on two monoclonal antibody treatments for COVID after they were deauthorized by the FDA, researchers report.
Study: One quarter of residents in licensed RCCs fell in past 90 days
Sep 01, 2022
A new analysis of national data has found that residents living in residential care communities are at high risk for falls and related injuries.